FilingReader Intelligence
Huapont Life Sciences director to sell 25% stake
July 27, 2025 at 07:50 AM UTC•By FilingReader AI
Huapont Life Sciences vice chairman Wang Rong plans to sell up to 2.7m shares, representing 25% of his current holding.
The sale will occur via centralized bidding on the Shenzhen Stock Exchange between August 19 and November 18, 2025, driven by personal funding needs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002004•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Huapont Life Sciences publishes news
Free account required • Unsubscribe anytime